Search alternatives:
points decrease » point decrease (Expand Search), point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
3 points » _ points (Expand Search), _ point (Expand Search), 5 point (Expand Search)
Showing 841 - 860 results of 229,627 for search '(( 3 points decrease ) OR ( 10 ((mean decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.98s Refine Results
  1. 841
    Decreased muscle damage but impaired fiber regeneration in <i>Hsp70</i><sup>−/−</sup> mice following muscle reloading-injury.

    Decreased muscle damage but impaired fiber regeneration in <i>Hsp70</i><sup>−/−</sup> mice following muscle reloading-injury. by Sarah M. Senf (405524)

    Published 2013
    Save to List
    Saved in:
  2. 842
    Treatment with blocking 10G7 but not with non-blocking 10F3 decreases overall virus loads as determined by whole body imaging.

    Treatment with blocking 10G7 but not with non-blocking 10F3 decreases overall virus loads as determined by whole body imaging. by Ren-Huan Xu (190315)

    Published 2012
    Save to List
    Saved in:
  3. 843
    Fig 3 -

    Fig 3 - by Jan Maleček (17396660)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 844
    Leukocyte infiltration <i>in vivo</i> is decreased by CLEC9A inhibition with H37Ra.

    Leukocyte infiltration <i>in vivo</i> is decreased by CLEC9A inhibition with H37Ra. by An-Chieh Cheng (4532641)

    Published 2017
    Save to List
    Saved in:
  5. 845
    Infection with <i>Salmonella</i> leads to decreased proportions of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes in the spleen.

    Infection with <i>Salmonella</i> leads to decreased proportions of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes in the spleen. by Kristin L. Rosche (754117)

    Published 2015
    Save to List
    Saved in:
  6. 846
    Cell treatment with the actin polymerization inhibitor Latrunculin B leads to decreased T3S translocation.

    Cell treatment with the actin polymerization inhibitor Latrunculin B leads to decreased T3S translocation. by Joëlle Mounier (267851)

    Published 2009
    Save to List
    Saved in:
  7. 847
    Manganase<sup>2+</sup> stimulation decreases association of ADAM17 to β1 integrin and leads to increased ADAM17 activity.

    Manganase<sup>2+</sup> stimulation decreases association of ADAM17 to β1 integrin and leads to increased ADAM17 activity. by Pal Gooz (330154)

    Published 2013
    Save to List
    Saved in:
  8. 848
    Proliferation marker phosphorylated histone H3 is decreased by rLOX-PP treatment.

    Proliferation marker phosphorylated histone H3 is decreased by rLOX-PP treatment. by Manish V. Bais (333481)

    Published 2013
    Save to List
    Saved in:
  9. 849
    Shifts in the microbiota over time are associated with increasing and decreasing phyla.

    Shifts in the microbiota over time are associated with increasing and decreasing phyla. by Joseph A. Edwards (4884340)

    Published 2018
    “…All regression coefficients used to construct panels B and C can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2003862#pbio.2003862.s003" target="_blank">S3 Data</a>.…”
    Save to List
    Saved in:
  10. 850
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 851
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 852
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 853
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 854
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 855
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 856
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 857
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 858
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 859
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 860
    ABCC3 overexpression decreases the retention of anti-cancer agents.

    ABCC3 overexpression decreases the retention of anti-cancer agents. by Sai A. Balaji (1452556)

    Published 2016
    Save to List
    Saved in:

Search Tools: